NAPLES, Fla., Sept. 05, 2017 -- HealthLynked Corp. (OTCQB:HLYK) today announced it has created 60,000 HealthLynked Provider profiles for every physician in Texas. Members now can search in Florida and Texas and find their Healthcare providers with over 110,000 profiles.
Creation of the HealthLynked provider network is an important step in allowing our patient members to search and "Lynk" to their healthcare providers anywhere in the U.S.
Dr. Michael Dent, Chairman and Chief Executive Officer, stated, “We are excited to expand our Provider Network and will soon be launching our sales and marketing efforts in Texas. We feel that the Texas market offers a unique opportunity to expand our network services as we continue our mission to create a nationwide network of Healthcare providers allowing patients’ healthcare records to move with them and be available to the healthcare providers they choose.”
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and healthcare providers to improve healthcare. The HealthLynked Network is a cloud-based platform that allows patients to enter their medical history, medications, allergies, past surgeries and medical records in one convenient online secure location, free of charge. Our patient member’s healthcare records move with them and are available to their healthcare providers. The HealthLynked network facilitates sharing of medical information across multiple electronic health records systems.
Participating healthcare providers realize benefits in the ability to see more patients, access more accurate patient information, participate in our telemedicine program, improve patient retention and increase online filing of vacancies including last minute cancelations through our “real time appointment scheduling” mobile application. Healthcare providers pay a monthly fee to increase online visibility, recruit new patients, and improve office efficiency.
For additional information about HealthLynked Corp. visit www.healthlynked.com
Forward Looking Statements
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward looking statements. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to gain new customers, offer new types of services, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's filings with the SEC.
Company Contact: George O’Leary Chief Financial Officer [email protected] Investor Relations contact: J Charles Assets, LLC Jay Hetrick [email protected]


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Italy Fines Apple €98.6 Million Over App Store Dominance
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



